Pasar al contenido principal

MIMETICOS DE GLICOCONJUGADOS: NUEVAS ESTRATEGIAS EN GLICOMEDICINA DIRIGIDAS A ENFERMEDADES NEUROLOGICAS Y DEL SISTEMA IMMUNE

PID2019-105858RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of (S-s)-DS-ONJ

  • Gómez Jaramillo, María Laura
  • Cano-Cano, Fátima
  • Sánchez-Fernández, Elena M.
  • Ortiz Mellet, Carmen
  • García-Fernández, José M.
  • Alcalá, Martin
  • Álvarez-Gallego, Fabiola
  • Iturregui, Marta
  • González Montelongo, María del Carmen
  • Campos Caro, Antonio
  • Arroba Espinosa, Ana Isabel
  • Aguilar Diosdado, Manuel
Inflammatory processes play a central role in the pathogenesis of diabetic nephropathy (DN) in the early stages of the disease. The authors demonstrate that the glycolipid mimetic (Ss)-DS-ONJ is able to abolish inflammation via the induction of autophagy flux and provokes the inhibition of inflammasome complex in ex vivo and in vitro models, using adult kidney explants from BB rats. The contribution of (Ss)-DS-ONJ to reducing inflammatory events is mediated by the inhibition of classical stress kinase pathways and the blocking of inflammasome complex activation. The (Ss)-DS-ONJ treatment is able to inhibit the epithelial-to-mesenchymal transition (EMT) progression, but only when the IL18 levels are reduced by the treatment. These findings suggest that (Ss)-DS-ONJ could be a novel, and multifactorial treatment for DN.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Fluoro-labelled sp2-iminoglycolipids with immunomodulatory properties

  • Padilla Pérez, M. Carmen
  • Sánchez Fernández, Elena M.
  • González Bakker, Aday
  • Puerta, Adrián
  • Martín Loro, Francisco
  • García Fernández, José Manuel
  • Padrón, José M.
  • Arroba Espinosa, Ana Isabel
  • Ortiz Mellet, Carmen
The unique electronic properties of the fluorine atom make its strategic incorporation into a bioactive compound a very useful tool in the design of drugs with optimized pharmacological properties. In the field of the carbohydrates, its selective installation at C2 position has proven particularly interesting, some 2-deoxy-2-fluorosugar derivatives being currently in the market. We have now transferred this feature into immunoregulatory glycolipid mimetics that contain a sp2-iminosugar moiety, namely sp2-iminoglycolipids (sp2-IGLs). The synthesis of two epimeric series of 2-deoxy-2-fluoro-sp2-IGLs, structurally related to nojirimycin and mannonojirimycin, has been accomplished by sequential Selectfluor-mediated fluorination and thioglycosidation of sp2-iminoglycals. Exclusively the α-anomer is obtained regardless of the configurational profile of the sp2-IGL (D-gluco or D-manno), highlighting the overwhelming anomeric effect in these prototypes. Notably, the combination of a fluorine atom at C2 and an α-oriented sulfonyl dodecyl lipid moiety in compound 11 led to remarkable anti-proliferative properties, featuring similar GI50 values than the chemotherapy drug Cisplatin against several tumor cell lines and better selectivity. The biochemical data further evidence a strong reduction of the number of tumor cell colonies and apoptosis induction. Mechanistic investigations revealed that this fluoro-sp2-IGL induces the non-canonical activation mode of the mitogen-activated protein kinase signaling pathway, causing p38α autoactivation under an inflammatory context., 19 páginas
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cyclodextrin-Based Nanostructure Efficiently Delivers siRNA to Glioblastoma Cells Preferentially via Macropinocytosis

  • Manzarares, Darío
  • Pérez-Carrión, María Dolores
  • Jiménez Blanco, José L.
  • Ortiz-Mellet, Carmen
  • García Fernández, José Manuel
  • Ceña, Valentín
© 2020 by the authors., Small interfering ribonucleic acid (siRNA) has the potential to revolutionize therapeutics since it can knockdown very efficiently the target protein. It is starting to be widely used to interfere with cell infection by HIV. However, naked siRNAs are unable to get into the cell, requiring the use of carriers to protect them from degradation and transporting them across the cell membrane. There is no information about which is the most efficient endocytosis route for high siRNA transfection efficiency. One of the most promising carriers to efficiently deliver siRNA are cyclodextrin derivatives. We have used nanocomplexes composed of siRNA and a β-cyclodextrin derivative, AMC6, with a very high transfection efficiency to selectively knockdown clathrin heavy chain, caveolin 1, and p21 Activated Kinase 1 to specifically block clathrin-mediated, caveolin-mediated and macropinocytosis endocytic pathways. The main objective was to identify whether there is a preferential endocytic pathway associated with high siRNA transfection efficiency. We have found that macropinocytosis is the preferential entry pathway for the nanoparticle and its associated siRNA cargo. However, blockade of macropinocytosis does not affect AMC6-mediated transfection efficiency, suggesting that macropinocytosis blockade can be functionally compensated by an increase in clathrin- and caveolin-mediated endocytosis., This research was funded, in part, by contract numbers PID2019-105858RB-I00 (MCI, AEI, FEDER, UE) and RTI2018-097609-B-C21 (MICIU, AEI, FEDER, UE) to C.O.M. and J.M.G.F. and grants from the Spanish Ministerio de Economía y Competitividad (project SAF2017-89288-R from MINECO/AEI/FEDER/UE), from Junta de Comunidades de Castilla-La Mancha (project SBPLY/19/180501/000067), and ISCIII (AC19/00075) and ERANET Euronanomed Program (project NANO4GLIO) to V.C. It also benefited from the framework of COST Action Nano2Clinic (CA17140), supported by COST (European Cooperation in Science and Technology)., Publisher’s version
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cyclodextrin-Based Functional Glyconanomaterials

  • Rivero-Barbarroja, Gonzalo
  • Benito, Juan M.
  • Ortiz-Mellet, Carmen
  • García Fernández, José Manuel
© 2020 by the authors., Cyclodextrins (CDs) have long occupied a prominent position in most pharmaceutical laboratories as “off-the-shelve” tools to manipulate the pharmacokinetics of a broad range of active principles, due to their unique combination of biocompatibility and inclusion abilities. The development of precision chemical methods for their selective functionalization, in combination with “click” multiconjugation procedures, have further leveraged the nanoscaffold nature of these oligosaccharides, creating a direct link between the glyco and the nano worlds. CDs have greatly contributed to understand and exploit the interactions between multivalent glycodisplays and carbohydrate-binding proteins (lectins) and to improve the drug-loading and functional properties of nanomaterials through host–guest strategies. The whole range of capabilities can be enabled through self-assembly, template-assisted assembly or covalent connection of CD/glycan building blocks. This review discusses the advancements made in this field during the last decade and the amazing variety of functional glyconanomaterials empowered by the versatility of the CD component., This research was funded by the Ministerio de Ciencia, Innovación y Universidades and the Agencia Estatal de Investigación (project RTI2018-097609-B-C21), the Ministerio de Ciencia e Innovación (PID2019-105858RB-I00), and the European Regional Development Funds (FEDER-UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis of sp2 -Iminosugar Selenoglycolipids as Multitarget Drug Candidates with Antiproliferative, Leishmanicidal and Anti-Inflammatory Properties

  • Sánchez-Fernández, Elena M.
  • García-Hernández, Raquel
  • Gamarro, Francisco
  • Arroba, Ana I.
  • Aguilar-Diosdado, Manuel
  • Padrón, José M.
  • García Fernández, José Manuel
  • Ortiz Mellet, Carmen
sp2-Iminosugar glycolipids (sp2-IGLs) represent a consolidated family of glycoconjugate mimetics encompassing a monosaccharide-like glycone moiety with a pseudoamide-type nitrogen replacing the endocyclic oxygen atom of carbohydrates and an axially-oriented lipid chain anchored at the pseudoanomeric position. The combination of these structural features makes them promising candidates for the treatment of a variety of conditions, spanning from cancer and inflammatory disorders to parasite infections. The exacerbated anomeric effect associated to the putative sp2-hybridized N-atom imparts chemical and enzymatic stability to sp2-IGLs and warrants total α-anomeric stereoselectivity in the key glycoconjugation step. A variety of O-, N-, C- and S-pseudoglycosides, differing in glycone configurational patterns and lipid nature, have been previously prepared and evaluated. Here we expand the chemical space of sp2-IGLs by reporting the synthesis of α-d-gluco-configured analogs with a bicyclic (5N,6O-oxomethylidene)nojirimycin (ONJ) core incorporating selenium at the glycosidic position. Structure–activity relationship studies in three different scenarios, namely cancer, Leishmaniasis and inflammation, convey that the therapeutic potential of the sp2-IGLs is highly dependent, not only on the length of the lipid chain (linear aliphatic C12 vs. C8), but also on the nature of the glycosidic atom (nitrogen vs. sulfur vs. selenium). The ensemble of results highlights the α-dodecylseleno-ONJ-glycoside as a promising multitarget drug candidate., This research was funded by the Spanish Ministerio de Economía y Competitividad (contract numbers PID2019-105858RB-I00), the Spanish Grant RTI2018-097210-B-100 (MCIU/AEI/FEDER, UE) to F.G., the European Regional Development Funds (FEDER and FSE). J.M.P. thanks the Spanish Government for financial support through project PGC2018-094503-B-C22 (MCIU/AEI/FEDER, UE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A selenoureido-iminoglycolipid transported by zeolitic-imidazolate framework nanoparticles: a novel antioxidant therapeutic approach

  • Guerrero, Fátima
  • Carmona, Andrés
  • Vidal, Victoria
  • Franco, Ana
  • Martín-Malo, Alejandro
  • Sánchez-Fernández, Elena M.
  • Carrillo-Carrión, Carolina
A selenium-containing metal-organic framework with remarkable antioxidant capacity and ROS-scavenging activity was constructed by a controlled de novo encapsulation approach of a glycoconjugate mimetic, specifically a sp2-iminoglycolipid bearing a selenoureido fragment (DSeU), within a zeolitic-imidazolate framework exoskeleton. Biocompatible and homogeneous nanosized particles of ∼70 nm (DSeU@ZIF8) were obtained, which could be efficiently internalized in cells, overcoming the poor solubility in biological media and limited bioavailability of glycolipids. The ZIF-particle served as nanocarrier for the intracellular delivery of the selenocompound to cells, promoted by the acidic pH inside endosomes/lysosomes. As demonstrated by in vitro studies, the designed DSeU@ZIF8 nanoparticles displayed a high antioxidant activity at low doses; lower intracellular ROS levels were observed upon the uptake of DSeU@ZIF8 by human endothelial cells. Even more interesting was the finding that these DSeU@ZIF8 particles were able to reverse to a certain level the oxidative stress induced in cells by pre-treatment with an oxidizing agent. This possibility of modulating the oxidative stress in living cells may have important implications in the treatment of diverse pathological complications that are generally accompanied with elevated ROS levels., This work was supported by grants from the Spanish Ministry of Science, Innovation and Universities and the Spanish Research Agency (RYC-2019-027527-I and PID2022-141034OB-C22 to C. C.-C., PID2019-105858RB-I00 and PID2022-141034OB-C21 to E. M. S.-F.) and from the Junta de Andalucía (CSyF 2022 project, PI-0130-2022 to F. G. and A.M.-M.). Financial support was also provided from the University of Seville (VIPPIT-2020-IV.2 to C. C.-C., and VIIPPIT-2022-V.1 Modality A2 to E. M. S.-F. and C. C.-C.). The authors are grateful to Dra. García Jurado from IMIBIC Microscopy Unit for her technical assistance. Technical assistance from the research support services of the University of Seville (CITIUS) is also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fluoro-labelled sp2-iminoglycolipids with immunomodulatory properties

  • Padilla-Pérez, M Carmen
  • Sánchez-Fernández, Elena M.
  • González-Bakker, Aday
  • Puerta, Adrián
  • Padrón, José M
  • Martín-Loro, Francisco
  • Arroba, Ana I.
  • García Fernández, José Manuel
  • Mellet, Carmen Ortiz
The unique electronic properties of the fluorine atom make its strategic incorporation into a bioactive compound a very useful tool in the design of drugs with optimized pharmacological properties. In the field of the carbohydrates, its selective installation at C2 position has proven particularly interesting, some 2-deoxy-2-fluorosugar derivatives being currently in the market. We have now transferred this feature into immunoregulatory glycolipid mimetics that contain a sp2-iminosugar moiety, namely sp2-iminoglycolipids (sp2-IGLs). The synthesis of two epimeric series of 2-deoxy-2-fluoro-sp2-IGLs, structurally related to nojirimycin and mannonojirimycin, has been accomplished by sequential Selectfluor-mediated fluorination and thioglycosidation of sp2-iminoglycals. Exclusively the α-anomer is obtained regardless of the configurational profile of the sp2-IGL (d-gluco or d-manno), highlighting the overwhelming anomeric effect in these prototypes. Notably, the combination of a fluorine atom at C2 and an α-oriented sulfonyl dodecyl lipid moiety in compound 11 led to remarkable anti-proliferative properties, featuring similar GI50 values than the chemotherapy drug Cisplatin against several tumor cell lines and better selectivity. The biochemical data further evidence a strong reduction of the number of tumor cell colonies and apoptosis induction. Mechanistic investigations revealed that this fluoro-sp2-IGL induces the non-canonical activation mode of the mitogen-activated protein kinase signaling pathway, causing p38α autoactivation under an inflammatory context., This work was supported by grants from the Ministerio de Ciencia e Innovación, the Agencia Estatal de Investigación and the European Regional Development Funds (PID2019-105858RB-I00) to COM. MCP-P is a FPU fellow (Grant number FPU19/04361). EMS-F thanks the VII Plan Propio de Investigación y Transferencia from the University of Seville (VIIPPIT-2022-V.1, Modality A2). JMGF was supported by grants from the Ministerio de Ciencia, Innovación y Universidades, the Agencia Estatal de Investigación and the European Regional Development Funds (RTI2018-097609-B-C21 and PID2021-124247OB-C21) and from the Junta de Andalucía and the European Regional Development Funds (P20_00166). Technical assistance from the research support services of the University of Seville (CITIUS) is also acknowledged. AG-B, AP and JMP thank the Spanish Government (Project PID2021-123059OB-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE). AP thanks the EU Social Fund (FSE) and the Canary Islands ACIISI for a predoctoral grant TESIS2020010055. AIA was supported by grants from Instituto de Salud Carlos III (PI22/01718), Consejería de Universidad, Investigación e Innovación de la Junta de Andalucía (PI20-01331) and Convocatoria de Subvenciones para la Financiación de la Investigación y la Innovación Biomédica y en Ciencias de la Salud en el Marco de la Iniciativa Territorial Integrada 2014-2020 para la Provincia de Cádiz, Fondos ITIFEDER. FM-L is FPI fellow (Grant number PI20-0036)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Potent and Selective Cell-Active Iminosugar Inhibitors of Human α-N-Acetylgalactosaminidase (α-NAGAL)

  • Ashmus, Roger A.
  • Wang, Yang
  • González-Cuesta, Manuel
  • King, Dustin T
  • Tiet, Ben
  • Chen, Xi
  • Zhu, Yanping
  • Kirk, Bryce
  • García Fernández, José Manuel
  • Ortiz-Mellet, Carmen
  • Britton, Robert
  • Vocadlo, David J
Glycoside hydrolases (GHs) are a class of enzymes with emerging roles in a range of disease. Selective GH inhibitors are sought to better understand their functions and assess the therapeutic potential of modulating their activities. Iminosugars are a promising class of GH inhibitors but typically lack the selectivity required to accurately perturb biological systems. Here, we describe a concise synthesis of iminosugar inhibitors of N-acetyl-α-galactosaminidase (α-NAGAL), the GH responsible for cleaving terminal α-N-acetylgalactosamine residues from glycoproteins and other glycoconjugates. Starting from non-carbohydrate precursors, this modular synthesis supported the identification of a potent (490 nM) and α-NAGAL selective (∼200-fold) guanidino-containing derivative DGJNGuan. To illustrate the cellular activity of this new inhibitor, we developed a quantitative fluorescence image-based method to measure levels of the Tn-antigen, a cellular glycoprotein substrate of α-NAGAL. Using this assay, we show that DGJNGuan exhibits excellent inhibition of α-NAGAL within cells using patient derived fibroblasts (EC50 =150 nM). Moreover, in vitro and in cell assays to assess levels of lysosomal β-hexosaminidase substrate ganglioside GM2 show that DGJNGuan is selective whereas DGJNAc exhibits off-target inhibition both in vitro and within cells. DGJNGuan is a readily produced and selective tool compound that should prove useful for investigating the physiological roles of α-NAGAL., The authors thank the Natural Sciences and Engineering Research Council of Canada (RGPIN-2020-05426 to DJV), AEI/10.13039/501100011033 (PID2019-105858RB-I00 to COM), MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe” (PID2021-124247OB-C21 to JMGF), and the Junta de Andalucía (P20_00166 and US-1380698 to COM) for financial support. RAA thanks the Michael Smith Foundation for Health Research for a fellowship. MG-C thanks FPI (BES-2017-079676) and University of Seville for fellowships. DJV thanks the Canada Research Chairs for a Tier I Canada Research Chair in Chemical Biology. The Centre for High-Throughput Chemical Biology (HTCB, SFU) and CITIUS (Univ. Seville) are thanked for technical support and for access to core facilities.Dr. Pierre-Andre Gilormini is thanked for expert assistance with graphics., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Reversible Light-Induced Dimerization of Secondary Face Azobenzene-Functionalized β-Cyclodextrin Derivatives

  • Rivero-Barbarroja, Gonzalo
  • Fernández-Clavero, Carlos
  • García-Iriepa, Cristina
  • Marcelo, Gema
  • Padilla-Pérez, M Carmen
  • Neva, Tania
  • Benito, Juan M.
  • Maisonneuve, Stéphane
  • Ortiz-Mellet, Carmen
  • Xie, Juan
  • García Fernández, José Manuel
  • Mendicuti, Francisco
β-cyclodextrin (βCyD) derivatives equipped with aromatic appendages at the secondary face exhibit tailorable self-assembling capabilities. The aromatic modules can participate in inclusion phenomena and/or aromatic-aromatic interactions. Supramolecular species can thus form that, at their turn, can engage in further co-assembling with third components in a highly regulated manner; the design of nonviral gene delivery systems is an illustrative example. Endowing such systems with stimuli responsiveness while keeping diastereomeric purity and a low synthetic effort is a highly wanted advancement. Here, we show that an azobenzene moiety can be "clicked" to a single secondary O-2 position of βCyD affording 1,2,3-triazole-linked βCyD-azobenzene derivatives that undergo reversible light-controlled self-organization into dimers where the monomer components face their secondary rims. Their photoswitching and supramolecular properties have been thoroughly characterized by UV-vis absorption, induced circular dichroism, nuclear magnetic resonance, and computational techniques. As model processes, the formation of inclusion complexes between a water-soluble triazolylazobenzene derivative and βCyD as well as the assembly of native βCyD/βCyD-azobenzene derivative heterodimers have been investigated in parallel. The stability of the host-guest supramolecules has been challenged against the competitor guest adamantylamine and the decrease of the medium polarity using methanol-water mixtures. The collective data support that the E-configured βCyD-azobenzene derivatives, in aqueous solution, form dimers stabilized by the interplay of aromatic-aromatic and aromatic-βCyD cavity interactions after partial reciprocal inclusion. Photoswitching to the Z-isomer disrupts the dimers into monomeric species, offering opportunity for the spatiotemporal control of the organizational status by light., The authors thank MCIN/AEI/10.13039/501100011033 (PID2019-105858RB-I00, to C.O.M, PID2020-118403GB-I00; PID2020-118384GB-I00; 119130GB-I00), and PID2020-MCIN/AEI/10.13039/961 501100011033 and “ERDF A way of making Europe” (PID2021-124247OB-C21), the Junta de Andalucía (P20_00166, US-1380698), the CAM (CM/JIN/2021-022), the COST action GLYCONanoPROBES (CM18132), and the Booster program of ENS Paris-Saclay for financial support. We also acknowledge the CITIUS (Univ. Seville) for technical support. G.R.-B and M.C.P.-P. are FPU fellows (Grant numbers FPU18/02922 and FPU19/04361, respectively). T.N. is grateful to Junta de Andalucía for a post-doctoral fellowship (contract number P12-FQM-1467). C.F.-C. thanks the UAH collaboration grant awarded., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Serine-/Cysteine-Based sp2-Iminoglycolipids as Novel TLR4 Agonists: Evaluation of Their Adjuvancy and Immunotherapeutic Properties in a Murine Model of Asthma

  • González-Cuesta, Manuel
  • Lai, Alan Chuan-Ying
  • Chi, Po-Yu
  • Hsu, I-Ling
  • Liu, Nien-Tzu
  • Wu, Ko-Chien
  • García Fernández, José Manuel
  • Chang, Ya-Jen
  • Ortiz-Mellet, Carmen
Glycolipids with TLR4 agonistic properties can serve either as therapeutic agents or as vaccine adjuvants by stimulating the development of proinflammatory responses. Translating them to the clinical setting is hampered by synthetic difficulties, the lack of stability in biological media, and/or a suboptimal profile of balanced immune mediator secretion. Here, we show that replacement of the sugar fragment by an sp2-iminosugar moiety in a prototypic TLR4 agonist, CCL-34, yields iminoglycolipid analogues that retain or improve their biological activity in vitro and in vivo and can be accessed through scalable protocols with total stereoselectivity. Their adjuvant potential is manifested in their ability to induce the secretion of proinflammatory cytokines, prime the maturation of dendritic cells, and promote the proliferation of CD8+ T cells, pertaining to a Th1-biased profile. Additionally, their therapeutic potential for the treatment of asthma, a Th2-dominated inflammatory pathology, has been confirmed in an ovalbumin-induced airway hyperreactivity mouse model., This work was financially supported by MCIN/AEI/10.13039/501100011033 and “ERDF A way of making Europe” (grant numbers PID2019-105858RB-I00 to C.O.M.; RTI2018-097609-B-C21 and PID2021-124247OB-C21 to J.M.G.F.) and the Junta de Andalucía (grant number P20_00166 to J.M.G.F.). This work was also supported by the Ministry of Science and Technology, Taiwan (111-2320-B-001-025-MY3 to Y.-J.C.), the Academia Sinica Investigator Award (AS-IA-110-L04 to Y.-J.C.), and the joint MOST-CSIC mobility action program (grant number OSTW200001 to Y.-J.C. and J.M.G.F.). The CITIUS (University of Seville) is also acknowledged for technical support. We would also like to thank the staff of the IBMS Flow Cytometry Core Facility, Academia Sinica (AS-CFII111-212), for flow cytometry and cell sorting services. M.G.-C. was supported by a postdoctoral fellowship (Contrato de Acceso al Sistema Español de Ciencia y Tecnología) funded by the University of Seville., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

High-Mannose Oligosaccharide Hemimimetics that Recapitulate the Conformation and Binding Mode to Concanavalin A, DC-SIGN and Langerin

  • Herrera-González, Irene
  • González-Cuesta, Manuel
  • Thépaut, Michel
  • Laigre, Eugénie
  • Goyard, David
  • Rojo, Francisco Javier
  • García Fernández, José Manuel
  • Fieschi, Franck
  • Renaudet, Olivier
  • Nieto, Pedro M.
  • Ortiz Mellet, Carmen
Chemicals and CAS Registry Numbers concanavalin A 11028-71-0 mannose 31103-86-3 Concanavalin A DC-specific ICAM-3 grabbing nonintegrin Lectins, C-Type Mannose Mannose-Binding Lectins Oligosaccharides, The "carbohydrate chemical mimicry" exhibited by sp2 -iminosugars has been utilized to develop practical syntheses for analogs of the branched high-mannose-type oligosaccharides (HMOs) Man3 and Man5 . In these compounds, the terminal nonreducing Man residues have been substituted with 5,6-oxomethylidenemannonojirimycin (OMJ) motifs. The resulting oligomannoside hemimimetic accurately reproduce the structure, configuration, and conformational behavior of the original mannooligosaccharides, as confirmed by NMR and computational techniques. Binding studies with mannose binding lectins, including concanavalin A, DC-SIGN, and langerin, by enzyme-linked lectin assay and surface plasmon resonance revealed significant variations in their ability to accommodate the OMJ unit in the mannose binding site. Intriguingly, OMJMan segments demonstrated "in line" heteromultivalent effects during binding to the three lectins. Similar to the mannobiose (Man2 ) branches in HMOs, the binding modes involving the external or internal monosaccharide unit at the carbohydrate binding-domain exist in equilibrium, facilitating sliding and recapture processes. This equilibrium, which influences the multivalent binding of HMOs, can be finely modulated upon incorporation of the OMJ sp2 -iminosugar caps. As a proof of concept, the affinity and selectivity towards DC-SIGN and langerin were adjustable by presenting the OMJMan epitope in platforms with diverse architectures and valencies., The authors thank AEI/10.13039/501100011033 (PID2019-105858RB-I00, to C.O.M.), AEI/10.13039/501100011033 and ‘‘ERDF A way of making Europe’’ (PID2020-118403GB-I00, PID2021-125094NB-I00, PID2021-124247OB-C21 and PID2022-141034OB-C21), the COST action GLYCONanoPROBES (CM18132), the Junta de Andalucía (US-1380698 and P20_00515), and the CITIUS (Univ. Seville), for technical support. J.M.G.F. acknowledges funding by the European Union's Horizon Europe research and innovation programme under the Marie Skłodowska-Curie grant agreement 101130235 – Bicyclos. E I. H.-G. was an FPU fellow (Grant FPU17/03147). M.G.-C. was supported by a postdoctoral fellowship (Contrato de Acceso al Sistema Español de Ciencia y Tecnologia) funded by the University of Seville This work used the platforms of the Grenoble Instruct-ERIC centre (ISBG; UMS 3518 CNRS-CEAUGA-EMBL) within the Grenoble Partnership for Structural Biology (PSB), supported by FRISBI (ANR-10-INBS-05-02) and GRAL, within the University Grenoble Alpes Graduate School CBH-EUR-GS (ANR-17-URE0003) and the Biomolecular Interaction Platform from cicCartuja (Sevilla). F. F. and O. R. acknowledge the French Agence Nationale de la Recherche PIA for Glyco@Alps (ANR-15-IDEX-02) and together with E.L., for her support, the ANR PRCI LectArray 19-CE18-0019-01. O.R. acknowledges the European Research Council Consolidator Grant “LEGO” (647938)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Speeding-up the Determination of Protein-Ligand Affinities by STD NMR: The Reduced Data Set STD NMR Approach (rd-STD NMR)

  • Rocha, Gabriel
  • Ramírez-Cárdenas, Jonathan
  • Padilla-Pérez, M Carmen
  • Walpole, Samuel
  • Nepravishta, Ridvan
  • García-Moreno, M. Isabel
  • Sánchez-Fernández, Elena M.
  • Ortiz-Mellet, Carmen
  • Angulo, Jesús
  • Muñoz-García, Juan C.
STD NMR spectroscopy is a powerful ligand-observed NMR tool for screening and characterizing the interactions of small molecules and low molecular weight fragments with a given macromolecule, identifying the main intermolecular contacts in the bound state. It is also a powerful analytical technique for the accurate determination of protein-ligand dissociation constants (KD) of medium-to-weak affinity, of interest in the pharmaceutical industry. However, accurate KD determination and epitope mapping requires a long series of experiments at increasing saturation times to carry out a full analysis using the so-called STD NMR build-up curve approach and apply the "initial slopes approximation". Here, we have developed a new protocol to bypass this important limitation, which allows us to obtain initial slopes by using just two saturation times and, hence, to very quickly determine precise protein-ligand dissociation constants by STD NMR., J.A., J.R.-C., and G.R. acknowledge the Ministerio de Ciencia e Innovación for funding through the grants PID2019-109395GB-I00 and PID2022-142879NB-I00. J.R.-C. also acknowledges the associated scholarship PRE2020-092754. J.A. and R.N. acknowledge support of BBSRC, grant BB/P010660/1. S.W. was funded by Biotechnology and Biological Sciences Research Council (BBSRC) Norwich Research Park Doctoral Training Grant BB/M011216/1. J.C.M.-G. thanks the European Commission for a HORIZON-TMA-MSCA-PF-EF grant (Sweet2Gel, ID 101064251). This work was supported by grants from the Ministerio de Ciencia e Innovacion, the Agencia Estatal de Investigacion and the European Regional Development Funds: AEI/10.13039/501100011033 (PID2019-105858RB-I00 to C.O.M and PID2022-141034OB-C21 to E.M.S.-F. and C.O.M). M.C.P.-P. is an FPU fellow (Grant number FPU19/04361). E.M.S.-F. thanks the VII Plan Propio de Investigación y Transferencia from the University of Seville (VIIPPIT-2022-V.1, Modality A2). Technical assistance from the research support services of the University of Seville (CITIUS) is also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

EXPLOITING AZOBENZENE-CYCLODEXTRIN INTERACTIONS FOR LIGHT-SENSITIVE NUCLEIC ACID DELIVERY

  • Rivero-Barbarroja, Gonzalo
  • Fernández-Clavero, Carlos
  • Garcia-Iriepa, Cristina
  • Marcelo, Gema
  • Padilla-Pérez, Maria del Carmen
  • Puerto-Madorran, Maria J.
  • Neva, Tania
  • Benito, Juan M.
  • Maisonneuve, Stephane
  • Ortiz-Mellet, Carmen
  • Xie, Joanne
  • Mendicuti, Francisco
  • García Fernández, José Manuel
comunicacion a congreso Poster P6, Incorporating an aromatic module onto a cyclodextrin (CyD) platform has proven to be highly advantageous for preorganizing the system in preparation for subsequent supramolecular events. Specifically, derivatives with an aromatic component on the secondary face of CyD exhibit controlled dimer formation. In these supramolecular species, the monomer components orient their secondary rims, with the aromatic moiety either absent or only partially included in the neighboring CyD partner cavity. This strategy has previously been employed to construct hierarchically assembled nanocomplexes, serving as artificial viruses for nucleic acid delivery.[1] The introduction of an azobenzene appendage as the aromatic component for dimerization offers the potential for light-responsive capabilities, thereby expanding the opportunities for spatiotemporal control over the assembly and dissociation equilibria. Azobenzene ability to reversibly switch between E- and Z-isomers upon irradiation at the appropriate wavelength significantly impacts molecular topology and is expected to influence self-organization processes. The extended E-isomer readily forms a 1:1 inclusion complex with the cavity of β-cyclodextrin (βCyD), while the twisted Z-diastereomer generally exhibits a lower association constant. In our continuous exploration of input-responsive cyclooligosaccharides with self-assembling behaviors,[2] we have demonstrated the efficient incorporation of the azobenzene motif at the O-2 position of βCyD derivatives through copper(I)-catalyzed azide-alkyne coupling (CuAAC).[3] Spectroscopic and computational techniques have confirmed the ability of the resulting adducts to reversibly form supramolecular dimers based on the configurational status of the triazolylazo-group, which can be modulated by light irradiation. Building on these findings, we propose the development of novel cationic CyD-based photoresponsive nonviral vectors, capitalizing on the differential inclusion capabilities of E and Z-triazolyl azobenzene guests or their distinct tendencies to facilitate hierarchical dimerization and co-assembly with nucleic acids (Figure 1)., Proyecto de I+D, Generación de conocimiento (Ref. PID2021-124247OB-C21, PID2019-105858RB-I00). Predoctoral fellowship FPU2018/02922 HORIZON-MSCA-2022-SE-01, Breaking down barriers to foster new Cyclodextrin-based applications for healthcare by implementing sustainable design principles "Bicyclos" (Ref. 101130235)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mannobioside biomimetics that trigger DC-SIGN binding selectivity

  • Herrera-González, Irene
  • Thépaut, Michel
  • Sánchez-Fernández, Elena M.
  • di Maio, Antonio
  • Vivès, Corinne
  • Rojo, Francisco Javier
  • García Fernández, José Manuel
  • Fieschi, Franck
  • Nieto, Pedro M.
  • Ortiz-Mellet, Carmen
Chemicals and CAS Registry Numbers Antigens, CD DC-specific ICAM-3 grabbing nonintegrin Lectins, C-Type Mannose-Binding Lectins, Selective DC-SIGN targeting vs. langerin might lead to anti-infective agents, given their counteracting effects upon infection by some pathogens. Here we show that multivalent sp2-iminosugar-containing mannobioside analogs can achieve total DC-SIGN selectivity by levering the canonic binding mode towards high-mannose oligosaccharide ligands, behaving as factual biomimics., The authors thank AEI/10.13039/501100011033 (PID2019105858RB-I00, to C.O.M.), MCIN/AEI/10.13039/501100011033 and ‘‘ERDF A way of making Europe’’ (RTI2018-097609-B-C21, PGC2018-099497-B100, PID2020-118403GB-I00 and PID2021124247OB-C21), the Junta de Andalucı´a (P20_00166, US-1380698), and the CITIUS (Univ. Seville), for technical support. I. H.-G. is an FPU fellow (Grant FPU17/03147). This work used the platforms of the Grenoble Instruct-ERIC centre (ISBG; UMS 3518 CNRS-CEAUGA-EMBL) within the Grenoble Partnership for Structural Biology (PSB), supported by FRISBI (ANR-10-INBS-05-02) and GRAL, within the University Grenoble Alpes Graduate School CBH-EUR-GS (ANR17- EURE0003). F. F. acknowledges the French Agence Nationale de la Recherche PIA for Glyco@Alps (ANR-15-IDEX-02)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bicyclic Picomolar OGA Inhibitors Enable Chemoproteomic Mapping of Its Endogenous Post-translational Modifications

  • González-Cuesta, Manuel
  • Sidhu, Peter
  • Ashmus, Roger A.
  • Males, Alexandra
  • Proceviat, Cameron
  • Madden, Zarina
  • Rogalski, Jason C.
  • Busmann, Jil A.
  • Foster, Leonard J.
  • García Fernández, José Manuel
  • Davies, Gideon J.
  • Ortiz-Mellet, Carmen
  • Vocadlo, David J.
Chemicals and CAS Registry Numbers glycosidase 9032-92-2 histone acetyltransferase 9054-51-7 histone acetyltransferase KAT5 hyaluronoglucosaminidase 37326-33-3 Antigens, Neoplasm beta-Hexosaminidase alpha Chain Bridged Bicyclo Compounds Enzyme Inhibitors HEXA protein, human Histone Acetyltransferases Hyaluronoglucosaminidase OGA protein, human Peptides Thiazolidines, Owing to its roles in human health and disease, the modification of nuclear, cytoplasmic, and mitochondrial proteins with O-linked N-acetylglucosamine residues (O-GlcNAc) has emerged as a topic of great interest. Despite the presence of O-GlcNAc on hundreds of proteins within cells, only two enzymes regulate this modification. One of these enzymes is O-GlcNAcase (OGA), a dimeric glycoside hydrolase that has a deep active site cleft in which diverse substrates are accommodated. Chemical tools to control OGA are emerging as essential resources for helping to decode the biochemical and cellular functions of the O-GlcNAc pathway. Here we describe rationally designed bicyclic thiazolidine inhibitors that exhibit superb selectivity and picomolar inhibition of human OGA. Structures of these inhibitors in complex with human OGA reveal the basis for their exceptional potency and show that they extend out of the enzyme active site cleft. Leveraging this structure, we create a high affinity chemoproteomic probe that enables simple one-step purification of endogenous OGA from brain and targeted proteomic mapping of its post-translational modifications. These data uncover a range of new modifications, including some that are less-known, such as O-ubiquitination and N-formylation. We expect that these inhibitors and chemoproteomics probes will prove useful as fundamental tools to decipher the mechanisms by which OGA is regulated and directed to its diverse cellular substrates. Moreover, the inhibitors and structures described here lay out a blueprint that will enable the creation of chemical probes and tools to interrogate OGA and other carbohydrate active enzymes., The authors are grateful for support from the Ministerio de Ciencia, Innovación y Universidades, the Ministerio de Ciencia e Innovación, the Agencia Estatal de Investigación, the European Regional Development Funds (projects RTI2018-097609-B-C21 and PID2019-105858RB-I00), the Junta de Andalucía, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, Genome Canada/Genome BC (264PRO), and the Canadian Institutes of Health Research (CIHR; PJT-148732, PJT-156202). DJV thanks the Canada Research Chairs program for support as a Tier I Canada Research Chair in Chemical Biology. RAA is supported by a trainee award from the Michael Smith Foundation Health Research (MSFHR). MG-C is a FPI fellow. Technical assistance from the research support services of the University of Seville (CITIUS) is also acknowledged. A.M. was funded by the Biotechnology and Biological Sciences Research Council (grant BB/M011151/1). G.J.D. is a Royal Society Ken Murray Research Professor. We thank Diamond Light Source for access to beamlines I03 and I04-1 (proposal No. mx-18598) that contributed to the results presented here, and Johan Turkenburg and Sam Hart for coordinating data collection., Peer reviewed